PortfoliosLab logoPortfoliosLab logo
HQH vs. BSTZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HQH vs. BSTZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tekla Healthcare Investors (HQH) and BlackRock Science and Technology Trust II (BSTZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HQH achieves a 5.47% return, which is significantly lower than BSTZ's 35.52% return.


HQH

1D
-1.83%
1M
-3.39%
YTD
5.47%
6M
3.99%
1Y
35.45%
3Y*
16.70%
5Y*
5.14%
10Y*
6.93%

BSTZ

1D
1.93%
1M
6.46%
YTD
35.52%
6M
37.09%
1Y
68.99%
3Y*
32.24%
5Y*
5.44%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HQH vs. BSTZ - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
HQH
Tekla Healthcare Investors
5.47%34.12%10.22%1.22%-17.27%7.99%24.82%10.86%
BSTZ
BlackRock Science and Technology Trust II
35.52%25.06%37.49%18.72%-55.34%12.71%87.46%4.20%

Correlation

The correlation between HQH and BSTZ is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.38

Correlation (5Y)
Calculated over the trailing 5-year period

0.50

Correlation (All Time)
Calculated using the full available price history since Jun 27, 2019

0.52

Over the past year, the correlation between HQH and BSTZ has dropped to 0.27 - well below their long-term average of 0.52, suggesting their price drivers have been diverging.

Fundamentals

EPS

HQH:

$6.05

BSTZ:

$8.53

PE Ratio

HQH:

3.10

BSTZ:

3.47

PEG Ratio

HQH:

0.21

BSTZ:

0.38

PS Ratio

HQH:

31.68

BSTZ:

5.63

Total Revenue (TTM)

HQH:

$32.46M

BSTZ:

$361.49M

Gross Profit (TTM)

HQH:

$27.34M

BSTZ:

$169.67M

EBITDA (TTM)

HQH:

$173.45M

BSTZ:

$586.67M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HQH vs. BSTZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HQH
HQH Risk / Return Rank: 8383
Overall Rank
HQH Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
HQH Sortino Ratio Rank: 8282
Sortino Ratio Rank
HQH Omega Ratio Rank: 8080
Omega Ratio Rank
HQH Calmar Ratio Rank: 8282
Calmar Ratio Rank
HQH Martin Ratio Rank: 8787
Martin Ratio Rank

BSTZ
BSTZ Risk / Return Rank: 9595
Overall Rank
BSTZ Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
BSTZ Sortino Ratio Rank: 9393
Sortino Ratio Rank
BSTZ Omega Ratio Rank: 9393
Omega Ratio Rank
BSTZ Calmar Ratio Rank: 9696
Calmar Ratio Rank
BSTZ Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HQH vs. BSTZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tekla Healthcare Investors (HQH) and BlackRock Science and Technology Trust II (BSTZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HQHBSTZDifference
Sharpe ratioReturn per unit of total volatility

-1.21

Sortino ratioReturn per unit of downside risk

-1.19

Omega ratioGain probability vs. loss probability

1.29

1.49

-0.20

Calmar ratioReturn relative to maximum drawdown

2.74

7.49

-4.75

Martin ratioReturn relative to average drawdown

9.58

23.14

-13.57

HQH vs. BSTZ - Sharpe Ratio Comparison

The current HQH Sharpe Ratio is 1.74, which is lower than the BSTZ Sharpe Ratio of 2.96. The chart below compares the historical Sharpe Ratios of HQH and BSTZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


HQHBSTZDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.74

2.96

-1.21

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.26

0.20

+0.07

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.32

Sharpe Ratio (All Time)

Calculated using the full available price history

0.37

0.51

-0.14

Drawdowns

HQH vs. BSTZ - Drawdown Comparison

The maximum HQH drawdown since its inception was -62.36%, roughly equal to the maximum BSTZ drawdown of -60.51%. Use the drawdown chart below to compare losses from any high point for HQH and BSTZ.


Loading charts...

Drawdown Indicators


HQHBSTZDifference

Max Drawdown

Largest peak-to-trough decline

-62.36%

-60.51%

-1.85%

Max Drawdown (1Y)

Largest decline over 1 year

-13.01%

-9.26%

-3.75%

Max Drawdown (3Y)

Largest decline over 3 years

-21.14%

-25.31%

+4.17%

Max Drawdown (5Y)

Largest decline over 5 years

-37.55%

-60.51%

+22.96%

Max Drawdown (10Y)

Largest decline over 10 years

-37.55%

Current Drawdown

Current decline from peak

-6.10%

-6.18%

+0.08%

Average Drawdown

Average peak-to-trough decline

-21.04%

-27.52%

+6.48%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.71%

2.99%

+0.72%

Volatility

HQH vs. BSTZ - Volatility Comparison

The current volatility for Tekla Healthcare Investors (HQH) is 5.83%, while BlackRock Science and Technology Trust II (BSTZ) has a volatility of 11.24%. This indicates that HQH experiences smaller price fluctuations and is considered to be less risky than BSTZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HQHBSTZDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.83%

11.24%

-5.41%

Volatility (6M)

Calculated over the trailing 6-month period

14.56%

20.16%

-5.60%

Volatility (1Y)

Calculated over the trailing 1-year period

20.49%

23.51%

-3.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.60%

27.63%

-8.03%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.51%

30.24%

-8.73%

Dividends

HQH vs. BSTZ - Dividend Comparison

HQH's dividend yield for the trailing twelve months is around 12.36%, more than BSTZ's 8.52% yield.


PositionTTM20252024202320222021202020192018201720162015
BSTZ
BlackRock Science and Technology Trust II
8.52%12.46%9.75%10.90%14.73%5.14%3.42%2.44%0.00%0.00%0.00%0.00%
HQH
Tekla Healthcare Investors
12.36%11.56%14.21%9.66%9.50%8.59%7.97%8.24%10.75%8.78%9.80%11.97%

Financials

HQH vs. BSTZ - Financials Comparison

This section allows you to compare key financial metrics between Tekla Healthcare Investors and BlackRock Science and Technology Trust II. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M20212022202320242025
17.03M
140.57M
(HQH) Total Revenue
(BSTZ) Total Revenue
Values in USD except per share items

Frequently Asked Questions


HQH and BSTZ have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BSTZ has higher volatility (11.24%) compared to HQH (5.83%). In terms of maximum drawdown, HQH dropped -62.36% vs BSTZ's -60.51%.

BSTZ currently has the higher Sharpe Ratio (2.96 vs 1.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HQH and BSTZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer